FullHope Biomedical Co (ROCO:7773) DeferredTaxAndRevenue: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
14 GF Score
Price NT$27.45
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co DeferredTaxAndRevenue?

FullHope Biomedical Co ROCO:7773 +3.58% 14 DeferredTaxAndRevenue is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

FullHope Biomedical Co's current deferred tax and revenue for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

FullHope Biomedical Co DeferredTaxAndRevenue Related Terms

FullHope Biomedical Co DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co DeferredTaxAndRevenue Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
0.00 0.00 0.00 0.00 0.00

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ROCO:7773
14GF Score
FullHope Biomedical Co Ltd ROCO:7773
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of NT$0.00 Mil mean?
FullHope Biomedical Co (ROCO:7773) has a DeferredTaxAndRevenue of NT$0.00 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on FullHope Biomedical Co.
Is FullHope Biomedical Co's DeferredTaxAndRevenue too high?
FullHope Biomedical Co's current DeferredTaxAndRevenue is NT$0.00 Mil. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's DeferredTaxAndRevenue compare to VRTX and REGN?
FullHope Biomedical Co's DeferredTaxAndRevenue of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on FullHope Biomedical Co. FullHope Biomedical Co's current DeferredTaxAndRevenue is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current DeferredTaxAndRevenue of NT$0.00 Mil. The current DeferredTaxAndRevenue is NT$0.00 Mil. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current DeferredTaxAndRevenue is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score

Get the complete analysis for ROCO:7773

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.45
Price